Xilio Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
XLO
CUSIP
98422T100
Type
Equity
Class
COM
Num filings
35
Total reported value, excl. options
$14.8 M
Manager Report Date Value ($000) Shares Option Type